Related Experiment Videos
Primary leiomyosarcoma of the fallopian tube
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Finite-time performance of a cyclic two-dimensional quantum Ising heat engine.
Physical review. E·2025
Kibble-Zurek Dynamics in the Anisotropic Ising Model of the Si(001) Surface.
Physical review letters·2025
Shedding light on the clinical recognition process of transient global amnesia.
European journal of neurology·2020
Polypharmacy in Parkinson's disease: risks and benefits with little evidence.
Journal of neural transmission (Vienna, Austria : 1996)·2019
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma: 5-year follow-up results from CheckMate 648.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
SKYSCRAPER-03: A Phase III Study of Tiragolumab Plus Atezolizumab Versus Durvalumab in Locally Advanced, Unresectable, Stage III NSCLC After Platinum-Based Concurrent Chemoradiation.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
A Multimodal Deep Learning Model for Preoperative Prediction of Postoperative Complications in Gastric Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
SACI-IO HR+: a randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Becotatug vedotin for recurrent/metastatic nasopharyngeal carcinoma (Magic-M001): a multicenter, randomized trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Prompt-directed ambient artificial intelligence for automated multidisciplinary tumor board documentation.
Annals of oncology : official journal of the European Society for Medical Oncology·2026